Kevin Stephens became finance director of the Almac Group at the beginning of the year, to lead the financial management teams for all global operations.
Stephens qualified as a chartered accountant with Ernst & Young and then worked for 14 years at Kemira NI as financial controller.
He joined Almac in 2001 and following a number of varied financial roles within the organisation, became Almac UK group financial controller in 2007. He was promoted to vice president, finance, Almac Group, in 2009, and in 2010 was appointed to the Almac executive team as executive vice president, finance.
You may also like
Manufacturing
Strategic outsourcing in pharma: building resilient partnerships for a complex future
In an era marked by rapid scientific advancement, increasing regulatory complexity and global supply chain volatility, the pharmaceutical industry faces unprecedented challenges. The need for agility, innovation and resilience is reshaping the traditional paradigms of drug development and manufacturing
Analysis
Overcoming the analytical method development hurdles associated with paediatric solid dosage forms
Developing analytical methods for paediatric solid dose products presents unique challenges that differ significantly from those encountered with adult formulations, reports Chloe Watson, Analytical Technical Leader at Almac Pharma Services